New Insights into Polymyxins: How Last-Resort Antibiotics Shatter Bacterial Defenses

Researchers have made a significant breakthrough in understanding how polymyxins, a class of crucial last-resort antibiotics, combat bacterial infections. These antibiotics, often used when other drugs fail, work by compelling bacterial cells to overproduce and shed their protective armor.

However, the effectiveness of polymyxins is limited to active bacteria, leaving dormant cells intact. This revelation provides insight into why certain infections recur repeatedly and suggests that new strategies could be developed to activate dormant cells prior to treatment, thereby enhancing the efficacy of antibiotics.

The discovery holds immense promise for public health, especially in an era where antibiotic resistance is a growing concern. As bacteria evolve to resist standard treatments, polymyxins remain a vital defense. Understanding their mechanism opens doors to combating troublesome bacteria more effectively.

The research underscores the importance of addressing bacterial activity levels when treating infections. By devising methods to 'wake up' bacteria, healthcare professionals could ensure that antibiotics do not leave behind any resilient remnants that could lead to recurring diseases.

These insights carry significant ramifications in Europe and globally, where antibiotic resistance poses a formidable challenge. Clever deployment of polymyxins, grounded in new scientific knowledge, might help in managing and controlling infections more successfully in the future.

Further investigations will likely explore how this discovery can translate into practical clinical applications, potentially reshaping the landscape of infectious disease management.

For more details, please see the original article at ScienceDaily: https://www.sciencedaily.com/releases/2025/09/250929054907.htm.